Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Roche stock down 5% after disappointing drug trial data update
September 11, 2024 1:22 PM EDTRoche (OTC: RHHBY) shares dropped 5.4% on Wednesday following an update about the early-stage trial of its weight-loss pill, CT-996.
The Swiss pharmaceutical giant said in July that the experimental pill resulted in a 6.1% placebo-adjusted weight loss over four weeks in a Phase I trial, creating optimism around its potential.... More
